Macquarie Group’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,728
Closed -$13 2580
2022
Q1
$13 Hold
3,728
﹤0.01% 2477
2021
Q4
$14K Buy
+3,728
New +$22.9K ﹤0.01% 2464

Other funds holding CLOV

Macquarie Group's CLOV Position: Q2 2022 in Review

Macquarie Group sold out of Clover Health Investments (CLOV) in Q2 2022, closing a stake of 3,728 shares — an estimated $13 sold.

Macquarie Group first reported a position in CLOV in Q4 2021 and held it in 2 quarters. The position peaked at $14K in Q4 2021. 176 funds tracked by Wall St. Rank hold CLOV as of Q2 2022.

  • Macquarie Group reported no remaining Clover Health Investments position as of Q2 2022 after selling out during the quarter.
  • Macquarie Group sold 3,728 Clover Health Investments shares in Q2 2022, an estimated $13.
  • Macquarie Group first reported a position in Clover Health Investments in Q4 2021 and held it in 2 quarters.
  • Macquarie Group's Clover Health Investments position peaked at $14K in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2022.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.